Banks Healthcare Sector

Sienna Senior Living

Market Cap: CA$1.6b

Provides senior living services in Canada.

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Aveanna Healthcare Holdings

Market Cap: US$1.1b

A diversified home care platform company, provides pediatric and adult healthcare services in the United States.

Pulse Biosciences

Market Cap: US$1.1b

Operates as a novel bioelectric medicine company.

Pacira BioSciences

Market Cap: US$1.1b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Innoviva

Market Cap: US$1.1b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

Natus Medical

Market Cap: US$1.1b

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide.

agilon health

Market Cap: US$1.1b

Provides healthcare services for seniors through primary care physicians in the communities of the United States.

Ocular Therapeutix

Market Cap: US$1.1b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

Amphastar Pharmaceuticals

Market Cap: US$1.1b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

NeoGenomics

Market Cap: US$1.1b

Operates a network of cancer-focused testing laboratories in the United States and the United Kingdom.

Evolent Health

Market Cap: US$1.1b

Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

Spire Healthcare Group

Market Cap: UK£799.1m

Owns and operates private hospitals and clinics in the United Kingdom.

MiMedx Group

Market Cap: US$1.1b

Develops and distributes placental tissue allografts for various sectors of healthcare.

Aurinia Pharmaceuticals

Market Cap: US$1.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.

Integra LifeSciences Holdings

Market Cap: US$1.0b

Manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

BioLife Solutions

Market Cap: US$1.0b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Viridian Therapeutics

Market Cap: US$1.0b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Neuren Pharmaceuticals

Market Cap: AU$1.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

OPKO Health

Market Cap: US$1.0b

A healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.

Gyre Therapeutics

Market Cap: US$1.0b

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

InMode

Market Cap: US$1.0b

Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.

Establishment Labs Holdings

Market Cap: US$1.0b

A medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.

Pennant Group

Market Cap: US$1.0b

Provides healthcare services in the United States.

Phibro Animal Health

Market Cap: US$997.1m

Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.

Mineralys Therapeutics

Market Cap: US$990.0m

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

Wave Life Sciences

Market Cap: US$984.9m

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Enliven Therapeutics

Market Cap: US$975.9m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

Novavax

Market Cap: US$965.3m

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Harrow

Market Cap: US$964.1m

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

Collegium Pharmaceutical

Market Cap: US$957.8m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

STAAR Surgical

Market Cap: US$940.7m

Designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

Arcus Biosciences

Market Cap: US$918.0m

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

Nanosonics

Market Cap: AU$1.4b

Operates as an infection prevention company globally.

Oculis Holding

Market Cap: US$914.9m

A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.

Craneware

Market Cap: UK£689.9m

Develops, licenses, and supports computer software for the healthcare industry in the United States.